The Use Of Praxion Varies In Each Region

Officers showed the Praxion syrup medicine at a pharmacy in Banda Aceh, Aceh (ANTARA PHOTO/Khalis Surry)

JAKARTA - Whether or not Praxion syrup can be consumed is not the same in some areas. Parents should not be confused.

Previously, PT Pharos Indonesia conducted a voluntary recall of the fever-reducing syrup drug, Praxion, as the responsibility of the pharmaceutical industry for incidents of pediatric patients with atypical progressive acute kidney failure (GGAPA).

Based on the company's official press release received in Jakarta, Tuesday afternoon, PT Pharos Indonesia conducted a product safety re-examination in its internal laboratory. Testing was carried out in accordance with the rules of the Indonesian Pharmacopoeia edition VI, supplement II.

However, the Food and Drug Supervisory Agency (BPOM) announced that Praxion syrup is safe for consumption based on a series of tests that have been carried out using seven samples with results that meet the requirements.

"From the results of testing the seven samples, the results met the requirements. This means that they meet the provisions and standards in the Indonesian pharmacopoeia," said the Acting Deputy for Supervision of Drugs, Narcotics, Psychotropics, Precursors, and Addictive Substances BPOM Togi Junice Hutadjulu.

Togi explained, the seven samples tested were samples of medicinal syrup and raw materials, which consisted of samples of leftover drug syrup from patients, syrup on the market, samples at the production site with the same batch, syrup samples from a batch adjacent to the patient's drug syrup.

Even though there has been an announcement from BPOM, the implementation in some areas is not the same.

The South Tangerang City Health Office, Banten, temporarily stopped the use of several variants of the Praxion syrup drug in all health facilities (faskes) as a measure to anticipate the reappearance of cases of acute kidney failure in children.

"So as a form of caution by the South Tangerang City Government, through the Health Service, it is notified for a temporary stop to the use of syrup drugs," said the Head of the South Tangerang City Health Office, Alin Hendalin Mahdaniar in a written statement received in Tangerang, Thursday, February 9, as reported by Antara.

The temporary suspension of the use of this syrup-type medicine is a follow-up to information regarding the recent emergence of cases of acute kidney failure and waiting for further instructions from the Republic of Indonesia's Food and Drug Monitoring Agency (BPOM).

Nevertheless, she also appealed to parents and the public to use drugs according to applicable regulations or under the supervision of doctors and health workers.

Meanwhile, the Papua Health Office stated that until now there has been no notification or circulation from the Food and Drug Supervisory Agency (BPOM) regarding the withdrawal of praxion syrup.

The head of the Pharmacy Section of the Papua Health Office, Sriyana, in Jayapura, admitted that until now there has been no notification from BPOM regarding the withdrawal of praxion syrup.

Until now there has been no notification from BPOM, so Praxion has not been withdrawn from circulation.

"If BPOM states that the drug must be withdrawn from circulation, we are ready to carry it out as was done when the drug withdrawal was requested by BPOM some time ago, namely Uniberi syrup," explained Sriyana.

Meanwhile, in Banda Aceh, Praxion syrup has been declared safe for consumption. This information has also been distributed to pharmacies or drugstores in the Aceh region so they can resell it.